1887

Chapter 2 : Genotypic Changes in Enterohemorrhagic During Human Infection

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

Genotypic Changes in Enterohemorrhagic During Human Infection, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817213/9781555817084_Chap02-1.gif /docserver/preview/fulltext/10.1128/9781555817213/9781555817084_Chap02-2.gif

Abstract:

The chapter begins with an overview of epidemiology and clinical pathogenesis of Enterohemorrhagic (EHEC). EHEC causes diarrhea, bloody diarrhea, and hemolytic-uremic syndrome (HUS). The major virulence factor of EHEC responsible for the microvascular endothelial injury is Shiga toxin (Stx). In additon to Stx, several other potential virulence determinants have been identified in EHEC. Next, the chapter focuses on genomes of EHEC. The lability of horizontally acquired genomic elements, such as pathogenicity islands, and especially of bacteriophages, increases the possibility of genomic alterations during human infections. Most EHEC strains possess one or more large plasmids. To investigate genetic changes of EHEC in patients with HUS, consecutive stool samples from such patients was analyzed by detecting and genes and by using a cytotoxicity assay to detect free Stx. Further, the chapter talks about interserotype differences in conversion of EHEC to EHEC-LST, and consequences of in vivo genetic changes in EHEC. To identify both EHEC and EHEC-LST in stool samples, detection of must be complemented by detection of -independent target(s) which are common to both pathotypes. Genetic changes in EHEC during infection might influence clinical outcome and have impacts on diagnosis, epidemiology, and evolution. For clinicians, awareness of a potential conversion of the pathotype of the infecting EHEC during infection is essential in making decisions about correct management of the patients and appropriate therapies.

Citation: Mellmann A, Bielaszewska M, Karch H. 2012. Genotypic Changes in Enterohemorrhagic During Human Infection, p 16-26. In Hacker J, Dobrindt U, Kurth R (ed), Genome Plasticity and Infectious Diseases. ASM Press, Washington, DC. doi: 10.1128/9781555817213.ch2

Key Concept Ranking

Type II Secretion System
0.43335778
Mobile Genetic Elements
0.4066154
0.43335778
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

Minimum spanning tree based on the allelic profiles of an MLST analysis of 42 / EHEC strains (red), representing all currently known serotypes and MLST sequence types (ST) of HUS-associated EHEC, and 17 / strains (EHEC-LST; green) from corresponding serogroups O26, O103, O121, O145, and O157. Each ST is represented by a circle labeled with its ST. The numbers on the connecting lines represent the number of differing alleles from the seven housekeeping genes of the MLST scheme. Clonal complexes (CC) are, if applicable, shaded in grey and named in accordance with the MLST website (http://mlst.ucc.ie/mlst/dbs/Ecoli)

Citation: Mellmann A, Bielaszewska M, Karch H. 2012. Genotypic Changes in Enterohemorrhagic During Human Infection, p 16-26. In Hacker J, Dobrindt U, Kurth R (ed), Genome Plasticity and Infectious Diseases. ASM Press, Washington, DC. doi: 10.1128/9781555817213.ch2
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2
FIGURE 2

Schematic presentation of loss and gain during the development of new EHEC clones by phage induction, release, and transduction of phages. Q, transcription activator, S, cell lysis protein.

Citation: Mellmann A, Bielaszewska M, Karch H. 2012. Genotypic Changes in Enterohemorrhagic During Human Infection, p 16-26. In Hacker J, Dobrindt U, Kurth R (ed), Genome Plasticity and Infectious Diseases. ASM Press, Washington, DC. doi: 10.1128/9781555817213.ch2
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555817213.chap2
1. Acheson, D. W.,, J. Reidl,, X. Zhang,, G. T. Keusch,, J. J. Mekalanos,, and M. K. Waldor. 1998. In vivo transduction with Shiga toxin 1-encoding phage. Infect. Immun. 66: 4496 4498.
2. Aldick, T.,, M. Bielaszewska,, W. Zhang,, J. Brockmeyer,, H. Schmidt,, A. W. Friedrich,, K. S. Kim,, M. A. Schmidt,, and H. Karch. 2007. Hemolysin from Shiga toxin-negative Escherichia coli O26 strains injures microvascular endothelium. Microbes Infect. 9: 282 290.
3. Alpers, K.,, D. Werber,, C. Frank,, J. Koch,, A. W. Friedrich,, H. Karch,, M. An der Heiden,, R. Prager,, A. Fruth,, M. Bielaszewska,, G. Morlock,, A. Heissenhuber,, A. Diedler,, A. Gerber,, and A. Ammon. 2009. Sorbitol-fermenting enterohaemorrhagic Escherichia coli O157:H causes another outbreak of haemolytic uraemic syndrome in children. Epidemiol. Infect. 137: 389 395.
4. Anjum, M. F.,, S. Lucchini,, A. Thompson,, J. C. D. Hinton,, and M. J. Woodward. 2003. Comparative genomic indexing reveals the phylogenomics of Escherichia coli pathogens. Infect. Immun. 71: 4674 4683.
5. Banatvala, N.,, P. M. Griffin,, K. D. Greene,, T. J. Barrett,, W. F. Bibb,, J. H. Green,, and J. G. Wells. 2001. The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings. J. Infect. Dis. 183: 1063 1070.
6. Bell, B. P.,, M. Goldoft,, P. M. Griffin,, M. A. Davis,, D. C. Gordon,, P. I. Tarr,, C. A. Bartleson,, J. H. Lewis,, T. J. Barrett,, and J. G. Wells. 1994. A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers: the Washington experience. JAMA 272: 1349 1353.
7. Beutin, L.,, G. Krause,, S. Zimmermann,, S. Kaulfuss,, and K. Gleier. 2004. Characterization of Shiga toxin-producing Escherichia coli strains isolated from human patients in Germany over a 3-year period. J. Clin. Microbiol. 42: 1099 1108.
8. Bielaszewska, M.,, B. Middendorf,, R. Kock,, A. W. Friedrich,, A. Fruth,, H. Karch,, M. A. Schmidt,, and A. Mellmann. 2008. Shiga toxin-negative attaching and effacing Escherichia coli: distinct clinical associations with bacterial phylogeny and virulence traits and inferred in-host pathogen evolution. Clin. Infect. Dis. 47: 208 217.
9. Bielaszewska, M.,, B. Sinha,, T. Kuczius,, and H. Karch. 2005a. Cytolethal distending toxin from Shiga toxin-producing Escherichia coli O157 causes irreversible G2/M arrest, inhibition of proliferation, and death of human endothelial cells. Infect. Immun. 73: 552 562.
10. Bielaszewska, M.,, M. Fell,, L. Greune,, R. Prager,, A. Fruth,, H. Tschäpe,, M. A. Schmidt,, and H. Karch. 2004. Characterization of cytolethal distending toxin genes and expression in Shiga toxin-producing Escherichia coli strains of non-O157 serogroups. Infect. Immun. 72: 1812 1816.
11. Bielaszewska, M.,, R. Köck,, A. Friedrich,, C. von Eiff,, L. Zimmerhackl,, H. Karch,, and A. Mellmann. 2007a. Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm? PLoS One 2: e1024.
12. Bielaszewska, M.,, R. Prager,, L. Vandivinit,, A. Müsken,, A. Mellmann,, N. J. Holt,, P. I. Tarr,, H. Karch,, and W. Zhang. 2009. Detection and characterization of fimbrial sfp cluster in enterohemorrhagic Escherichia coli O165:H25/NM from humans and cattle. Appl. Environ. Microbiol. 75: 64 71.
13. Bielaszewska, M.,, R. Prager,, R. Köck,, A. Mellmann,, W. Zhang,, H. Tschäpe,, P. I. Tarr,, and H. Karch. 2007b. Shiga toxin gene loss and transfer in vitro and in vivo during enterohemorrhagic Escherichia coli O26 infection in humans. Appl. Environ. Microbiol. 73: 3144 3150.
14. Bielaszewska, M.,, W. Zhang,, P. I. Tarr,, A. Sonntag,, and H. Karch. 2005b. Molecular profiling and phenotype analysis of Escherichia coli O26:H11 and O26:NM: secular and geographic consistency of enterohemorrhagic and enteropathogenic isolates. J. Clin. Microbiol. 43: 4225 4228.
15. Bielaszewska, M.,, and H. Karch. 2005. Consequences of enterohaemorrhagic Escherichia coli infection for the vascular endothelium. Thromb. Haemost. 94: 312 318.
16. Bono, J. L.,, J. E. Keen,, M. L. Clawson,, L. M. Durso,, M. P. Heaton,, and W. W. Laegreid. 2007. Association of Escherichia coli O157:H7 tir polymorphisms with human infection. BMC Infect. Dis. 7: 98.
17. Brockmeyer, J.,, M. Bielaszewska,, A. Fruth,, M. L. Bonn,, A. Mellmann,, H. Humpf,, and H. Karch. 2007. Subtypes of the plasmid-encoded serine protease EspP in Shiga toxin-producing Escherichia coli: distribution, secretion, and proteolytic activity. Appl. Environ. Microbiol. 73: 6351 6359.
18. Brooks, J. T.,, E. G. Sowers,, J. G. Wells,, K. D. Greene,, P. M. Griffin,, R. M. Hoekstra,, and N. A. Strockbine. 2005. Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002. J. Infect. Dis. 192: 1422 1429.
19. Brunder, W.,, H. Karch,, and H. Schmidt. 2006. Complete sequence of the large virulence plasmid pSFO157 of the sorbitol-fermenting enterohemorrhagic Escherichia coli O157:H strain 3072/96. Int. J. Med. Microbiol. 296: 467 474.
20. Brunder, W.,, H. Schmidt,, M. Frosch,, and H. Karch. 1999. The large plasmids of Shiga toxin-producing Escherichia coli (STEC) are highly variable genetic elements. Microbiology 145: 1005 1014.
21. Brunder, W.,, H. Schmidt,, and H. Karch. 1997. EspP, a novel extracellular serine protease of enterohaemorrhagic Escherichia coli O157:H7 cleaves human coagulation factor V. Mol. Microbiol. 24: 767 778.
22. Caprioli, A.,, S. Morabito,, H. Brugere,, and E. Oswald. 2005. Enterohaemorrhagic Escherichia coli: emerging issues on virulence and modes of transmission. Vet. Res. 36: 289 311.
23. Centers for Disease Control and Prevention. 2006. Ongoing multistate outbreak of Escherichia coli serotype O157:H7 infections associated with consumption of fresh spinach—United States, September 2006. MMWR Morb. Mortal. Wkly. Rep. 55: 10451046.
24. Cornick, N. A.,, A. F. Helgerson,, V. Mai,, J. M. Ritchie,, and D. W. K. Acheson. 2006. In vivo transduction of an Stx-encoding phage in ruminants. Appl. Environ. Microbiol. 72: 5086 5088.
25. Creuzburg, K.,, B. Kohler,, H. Hempel,, P. Schreier,, E. Jacobs,, and H. Schmidt. 2005. Genetic structure and chromosomal integration site of the cryptic prophage CP-1639 encoding Shiga toxin 1. Microbiology 151: 941 950.
26. Crump, J. A.,, A. C. Sulka,, A. J. Langer,, C. Schaben,, A. S. Crielly,, R. Gage,, M. Baysinger,, M. Moll,, G. Withers,, D. M. Toney,, S. B. Hunter,, R. M. Hoekstra,, S. K. Wong,, P. M. Griffin,, and T. J. Van Gilder. 2002. An outbreak of Escherichia coli O157:H7 infections among visitors to a dairy farm. N. Engl. J. Med. 347: 555 560.
27. Elliott, E. J.,, R. M. Robins-Browne,, E. V. O’Loughlin,, V. Bennett-Wood,, J. Bourke,, P. Henning,, G. G. Hogg,, J. Knight,, H. Powell,, and D. Redmond. 2001. Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features. Arch. Dis. Child. 85: 125 131.
28. Feng, P.,, M. Dey,, A. Abe,, and T. Takeda. 2001. Isogenic strain of Escherichia coli O157:H7 that has lost both Shiga toxin 1 and 2 genes. Clin. Diagn. Lab. Immunol. 8: 711 717.
29. Friedrich, A. W.,, K. V. Nierhoff,, M. Bielaszewska,, A. Mellmann,, and H. Karch. 2004. Phylogeny, clinical associations, and diagnostic utility of the pilin subunit gene ( sfpA) of sorbitol-fermenting, enterohemorrhagic Escherichia coli O157:H . J. Clin. Microbiol. 42: 4697 4701.
30. Friedrich, A. W.,, M. Bielaszewska,, W. Zhang,, M. Pulz,, T. Kuczius,, A. Ammon,, and H. Karch. 2002. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J. Infect. Dis. 185: 74 84.
31. Friedrich, A. W.,, S. Lu,, M. Bielaszewska,, R. Prager,, P. Bruns,, J. Xu,, H. Tschäpe,, and H. Karch. 2006. Cytolethal distending toxin in Escherichia coli O157:H7: spectrum of conservation, structure, and endothelial toxicity. J. Clin. Microbiol. 44: 1844 1846.
32. Friedrich, A. W.,, W. Zhang,, M. Bielaszewska,, A. Mellmann,, R. Köck,, A. Fruth,, H. Tschäpe,, and H. Karch. 2007. Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans. Clin. Infect. Dis. 45: 39 45.
33. Garg, A. X.,, R. S. Suri,, N. Barrowman,, F. Rehman,, D. Matsell,, M. P. Rosas-Arellano,, M. Salvadori,, R. B. Haynes,, and W. F. Clark. 2003. Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression. JAMA 290: 1360 1370.
34. Gerber, A.,, H. Karch,, F. Allerberger,, H. M. Verweyen,, and L. B. Zimmerhackl. 2002. Clinical course and the role of Shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study. J. Infect. Dis. 186: 493 500.
35. Hayashi, T.,, K. Makino,, M. Ohnishi,, K. Kurokawa,, K. Ishii,, K. Yokoyama,, C. G. Han,, E. Ohtsubo,, K. Nakayama,, T. Murata,, M. Tanaka,, T. Tobe,, T. Iida,, H. Takami,, T. Honda,, C. Sasakawa,, N. Ogasawara,, T. Yasunaga,, S. Kuhara,, T. Shiba,, M. Hattori, and M, Shinagawa. 2001. Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12. DNA Res. 8: 11 22.
36. Hilborn, E. D.,, J. H. Mermin,, P. A. Mshar,, J. L. Hadler,, A. Voetsch,, C. Wojtkunski,, M. Swartz,, R. Mshar,, M. A. Lambert-Fair,, J. A. Farrar,, M. K. Glynn,, and L. Slutsker. 1999. A multistate outbreak of Escherichia coli O157:H7 infections associated with consumption of mesclun lettuce. Arch. Intern. Med. 159: 1758 1764.
37. Holme, R. 2003. Drinking water contamination in Walkerton, Ontario: positive resolutions from a tragic event. Water Sci. Technol. 47: 1 6.
38. Janka, A.,, M. Bielaszewska,, U. Dobrindt,, L. Greune,, M. A. Schmidt,, and H. Karch. 2003. Cytolethal distending toxin gene cluster in enterohemorrhagic Escherichia coli O157:H and O157:H7: characterization and evolutionary considerations. Infect. Immun. 71: 3634 3638.
39. Jelacic, J. K.,, T. Damrow,, G. S. Chen,, S. Jelacic,, M. Bielaszewska,, M. Ciol,, H. M. Carvalho,, A. R. Melton-Celsa,, A. D. O’Brien,, and P. I. Tarr. 2003. Shiga toxin-producing Escherichia coli in Montana: bacterial genotypes and clinical profiles. J. Infect. Dis. 188: 719 729.
40. Johnson, K. E.,, C. M. Thorpe,, and C. L. Sears. 2006. The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. Clin. Infect. Dis. 43: 1587 1595.
41. Karch, H.,, P. I. Tarr,, and M. Bielaszewska. 2005. Enterohaemorrhagic Escherichia coli in human medicine. Int. J. Med. Microbiol. 295: 405 418.
42. Klein, E. J.,, J. R. Stapp,, C. R. Clausen,, D. R. Boster,, J. G. Wells,, X. Qin,, D. L. Swerdlow,, and P. I. Tarr. 2002. Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study. J. Pediatr. 141: 172 177.
43. Kudva, I. T.,, P. S. Evans,, N. T. Perna,, T. J. Barrett,, F. M. Ausubel,, F. R. Blattner,, and S. B. Calderwood. 2002. Strains of Escherichia coli O157:H7 differ primarily by insertions or deletions, not single-nucleotide polymorphisms. J. Bacteriol. 184: 1873 1879.
44. Lee, J. H.,, and S. Choi. 2006. Isolation and characteristics of sorbitol-fermenting Escherichia coli O157 strains from cattle. Microbes Infect. 8: 2021 2026.
45. Leopold, S. R.,, V. Magrini,, N. J. Holt,, N. Shaikh,, E. R. Mardis,, J. Cagno,, Y. Ogura,, A. Iguchi,, T. Hayashi,, A. Mellmann,, H. Karch,, T. E. Besser,, S. A. Sawyer,, T. S. Whittam,, and P. I. Tarr. 2009. A precise reconstruction of the emergence and constrained radiations of Escherichia coli O157 portrayed by backbone concatenomic analysis. Proc. Natl. Acad. Sci. USA 106: 8713 8718.
46. Levine, M. M.,, J. G. Xu,, J. B. Kaper,, H. Lior,, V. Prado,, B. Tall,, J. Nataro,, H. Karch,, and K. Wachsmuth. 1987. A DNA probe to identify enterohemorrhagic Escherichia coli of O157:H7 and other serotypes that cause hemorrhagic colitis and hemolytic uremic syndrome. J. Infect. Dis. 156: 175 182.
47. Manning, S. D.,, A. S. Motiwala,, A. C. Springman,, W. Qi,, D. W. Lacher,, L. M. Ouellette,, J. M. Mladonicky,, P. Somsel,, J. T. Rudrik,, S. E. Dietrich,, W. Zhang,, B. Swaminathan,, D. Alland,, and T. Whittam. 2008. Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks. Proc. Natl. Acad. Sci. USA 105: 4868 4873.
48. Mellmann, A.,, M. Bielaszewska,, L. B. Zimmerhackl,, R. Prager,, D. Harmsen,, H. Tschäpe,, and H. Karch. 2005. Enterohemorrhagic Escherichia coli in human infection: in vivo evolution of a bacterial pathogen. Clin. Infect. Dis. 41: 785 792.
49. Mellmann, A.,, S. Lu,, H. Karch,, J. Xu,, D. Harmsen,, M. A. Schmidt,, and M. Bielaszewska. 2008. Recycling of Shiga toxin 2 genes in sorbitol-fermenting enterohemorrhagic Escherichia coli O157:NM. Appl. Environ. Microbiol. 74: 67 72.
50. Michino, H.,, K. Araki,, S. Minami,, S. Takaya,, N. Sakai,, M. Miyazaki,, A. Ono,, and H. Yanagawa. 1999. Massive outbreak of Escherichia coli O157:H7 infection in schoolchildren in Sakai City, Japan, associated with consumption of white radish sprouts. Am. J. Epidemiol. 150: 787 796.
51. Müller, D.,, L. Greune,, G. Heusipp,, H. Karch,, A. Fruth,, H. Tschäpe,, and M. A. Schmidt. 2007. Identification of unconventional intestinal pathogenic Escherichia coli isolates expressing intermediate virulence factor profiles by using a novel single-step multiplex PCR. Appl. Environ. Microbiol. 73: 3380 3390.
52. Muniesa, M.,, M. de Simon,, G. Prats,, D. Ferrer,, H. Panella,, and J. Jofre. 2003. Shiga toxin 2-converting bacteriophages associated with clonal variability in Escherichia coli O157:H7 strains of human origin isolated from a single outbreak. Infect. Immun. 71: 4554 4562.
53. Murase, T.,, S. Yamai,, and H. Watanabe. 1999. Changes in pulsed-field gel electrophoresis patterns in clinical isolates of enterohemorrhagic Escherichia coli O157:H7 associated with loss of Shiga toxin genes. Curr. Microbiol. 38: 48 50.
54. Müsken, A.,, M. Bielaszewska,, L. Greune,, C. H. Schweppe,, J. Müthing,, H. Schmidt,, M. A. Schmidt,, H. Karch,, and W. Zhang. 2008. Anaerobic conditions promote expression of Sfp fimbriae and adherence of sorbitol-fermenting enterohemorrhagic Escherichia coli O157:NM to human intestinal epithelial cells. Appl. Environ. Microbiol. 74: 1087 1093.
55. Müthing, J.,, and U. Distler. 2010. Advances on the compositional analysis of glycosphingolipids combining thin-layer chromatography with mass spectrometry. Mass. Spectrom. Rev. 29: 425 479.
56. Ogura, Y.,, T. Ooka,, A. Iguchi,, H. Toh,, M. Asadulghani,, K. Oshima,, T. Kodama,, H. Abe,, K. Nakayama,, K. Kurokawa,, T. Tobe,, M. Hattori,, and T. Hayashi. 2009. Comparative genomics reveal the mechanism of the parallel evolution of O157 and non-O157 enterohemorrhagic Escherichia coli. Proc. Natl. Acad. Sci. USA 106: 17939 17944.
57. Paros, M.,, P. I. Tarr,, H. Kim,, T. E. Besser,, and D. D. Hancock. 1993. A comparison of human and bovine Escherichia coli O157:H7 isolates by toxin genotype, plasmid profile, and bacteriophage lambda-restriction fragment length polymorphism profile. J. Infect. Dis. 168: 1300 1303.
58. Paton, A. W.,, P. Srimanote,, U. M. Talbot,, H. Wang,, and J. C. Paton. 2004. A new family of potent AB(5) cytotoxins produced by Shiga toxigenic Escherichia coli. J. Exp. Med. 200: 35 46.
59. Perna, N. T.,, G. Plunkett,, V. Burland,, B. Mau,, J. D. Glasner,, D. J. Rose,, G. F. Mayhew,, P. S. Evans,, J. Gregor,, H. A. Kirkpatrick,, G. Posfai,, J. Hackett,, S. Klink,, A. Boutin,, Y. Shao,, L. Miller,, E. J. Grotbeck,, N. W. Davis,, A. Lim,, E. T. Dimalanta,, K. D. Potamousis,, J. Apodaca,, T. S. Anantharaman,, J. Lin,, G. Yen,, D. C. Schwartz,, R. A. Welch,, and F. R. Blattner. 2001. Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature 409: 529 533.
60. Richardson, S. E.,, M. A. Karmali,, L. E. Becker,, and C. R. Smith. 1988. The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. Hum. Pathol. 19: 1102 1108.
61. Riley, L. W.,, R. S. Remis,, S. D. Helgerson,, H. B. McGee,, J. G. Wells,, B. R. Davis,, R. J. Hebert,, E. S. Olcott,, L. M. Johnson,, N. T. Hargrett,, P. A. Blake,, and M. L. Cohen. 1983. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N. Engl. J. Med. 308: 681 685.
62. Schimmer, B.,, K. Nygard,, H. Eriksen,, J. Lassen,, B. Lindstedt,, L. T. Brandal,, G. Kapperud,, and P. Aavitsland. 2008. Outbreak of haemolytic uraemic syndrome in Norway caused by stx2 positive Escherichia coli O103:H25 traced to cured mutton sausages. BMC Infect. Dis. 8: 41.
63. Schmidt, H.,, L. Beutin,, and H. Karch. 1995. Molecular analysis of the plasmid-encoded hemolysin of Escherichia coli O157:H7 strain EDL 933. Infect. Immun. 63: 1055 1061.
64. Sonntag, A.,, R. Prager,, M. Bielaszewska,, W. Zhang,, A. Fruth,, H. Tschäpe,, and H. Karch. 2004. Phenotypic and genotypic analyses of enterohemorrhagic Escherichia coli O145 strains from patients in Germany. J. Clin. Microbiol. 42: 954 962.
65. Tarr, P. I.,, C. A. Gordon,, and W. L. Chandler. 2005. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365: 1073 1086.
66. Toth, I.,, H. Schmidt,, M. Dow,, A. Malik,, E. Oswald,, and B. Nagy. 2003. Transduction of porcine enteropathogenic Escherichia coli with a derivative of a Shiga toxin 2-encoding bacteriophage in a porcine ligated ileal loop system. Appl. Environ. Microbiol. 69: 7242 7247.
67. Waddell, T.,, S. Head,, M. Petric,, A. Cohen,, and C. Lingwood. 1988. Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2. Biochem. Biophys. Res. Commun. 152: 674 679.
68. Wagner, P. L.,, and M. K. Waldor. 2002. Bacteriophage control of bacterial virulence. Infect. Immun. 70: 3985 3993.
69. Werber, D.,, B. W. Mason,, M. R. Evans,, and R. L. Salmon. 2008. Preventing household transmission of Shiga toxin-producing Escherichia coli O157 infection: promptly separating siblings might be the key. Clin. Infect. Dis. 46: 1189 1196.
70. Yu, J.,, and J. B. Kaper. 1992. Cloning and characterization of the eae gene of enterohaemorrhagic Escherichia coli O157:H7. Mol. Microbiol. 6: 411 417.
71. Zhang, W.,, A. Mellmann,, A. Sonntag,, L. Wieler,, M. Bielaszewska,, H. Tschäpe,, H. Karch,, and A. W. Friedrich. 2007. Structural and functional differences between disease-associated genes of enterohaemorrhagic Escherichia coli O111. Int. J. Med. Microbiol. 297: 17 26.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error